Cargando…

HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience

Erythropoiesis-stimulating agents, such as recombinant human erythropoietin, are commonly used for the treatment of anemia in patients with chronic kidney disease (CKD). In 2007, HX575 (Binocrit(®)) became the first biosimilar epoetin alfa to be approved by the European Medicines Agency (EMA). The d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dellanna, Frank, Goldsmith, David, Krendyukov, Andriy, Seidl, Andreas, Höbel, Nadja, Combe, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739117/ https://www.ncbi.nlm.nih.gov/pubmed/29296077 http://dx.doi.org/10.2147/DDDT.S146147

Ejemplares similares

Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study
por: London, Gérard, et al.
Publicado: (2018)

Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?
por: Goldsmith, David, et al.
Publicado: (2018)

Development and 10-year history of a biosimilar: the example of Binocrit(®)
por: Aapro, Matti, et al.
Publicado: (2018)

Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients
por: Casadevall, Nicole, et al.
Publicado: (2017)

Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study
por: Aapro, Matti, et al.
Publicado: (2019)

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained
por: Aapro, Matti, et al.
Publicado: (2018)

Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
por: Gascon, Pere, et al.
Publicado: (2019)

Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
por: Krendyukov, A., et al.
Publicado: (2017)

Extrapolation concept at work with biosimilar: a decade of experience in oncology
por: Krendyukov, Andriy, et al.
Publicado: (2018)

Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study
por: Combe, Christian, et al.
Publicado: (2019)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial
por: Sörgel, Fritz, et al.
Publicado: (2009)

Breaking the HxNy outbreak
por: Manikandan, Jayapal, et al.
Publicado: (2010)

Ten years’ clinical experience with biosimilar human growth hormone: a review of efficacy data
por: López-Siguero, Juan Pedro, et al.
Publicado: (2017)

Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
por: Borrás Pérez, Maria Victoria, et al.
Publicado: (2017)

Run 575 MD - 75.03.10: Vacuum experiment in Sector 21
por: Fischer, E
Publicado: (1975)

Mozart Streichquartette KV421 & 575
por: Mozart, Wolfgang Amadeus, 1756-1791

Thermal Properties of Bayfol(®) HX200 Photopolymer
por: Blanche, Pierre-Alexandre, et al.
Publicado: (2020)

Phylogenomics of 10,575 genomes reveals evolutionary proximity between domains Bacteria and Archaea
por: Zhu, Qiyun, et al.
Publicado: (2019)

SUN-575 Anabolic Steroids Induced Hyperthyroidism
por: Aljaberi, Asma, et al.
Publicado: (2019)

575 Are There Racial Disparities in Burn Center Care?
por: Bessey, Palmer Q, et al.
Publicado: (2022)

The Chemistry and Physics of Bayfol(®) HX Film Holographic Photopolymer
por: Bruder, Friedrich-Karl, et al.
Publicado: (2017)

Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies
por: Krendyukov, Andriy, et al.
Publicado: (2019)

Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer
por: Maduell, Francisco, et al.
Publicado: (2023)

Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
por: Krendyukov, Andriy
Publicado: (2020)

Innovative oncology products: time to revisit the strategy development?
por: Krendyukov, Andriy
Publicado: (2019)

Run 575, 10.3.1975, Ring 2, 26 GeV: Blow-up of the bunch area
por: Hofmann, A
Publicado: (1975)

Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases
por: Alejo, Maria, et al.
Publicado: (2018)

Accuracy of ED Bedside Ultrasound for Identification of gallstones: retrospective analysis of 575 studies
por: Scruggs, William, et al.
Publicado: (2008)

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients
por: Kurtz, Jean-Emmanuel, et al.
Publicado: (2016)

Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)
por: Gesualdo, Loreto, et al.
Publicado: (2015)

Medical thoracoscopy for tuberculous pleurisy: A retrospective analysis of 575 cases
por: Zhao, Tingting, et al.
Publicado: (2019)

Analysis of relative displacement between the HX wearable robotic exoskeleton and the user’s hand
por: Cempini, Marco, et al.
Publicado: (2014)

Electrochemical Oxidative Clean Halogenation Using HX/NaX with Hydrogen Evolution
por: Yuan, Yong, et al.
Publicado: (2019)

Basic features of Ne*–HX (X = Cl, Br) chemi-ionization reactions
por: Falcinelli, Stefano, et al.
Publicado: (2022)

Botanical preparation HX109 inhibits macrophage-mediated activation of prostate epithelial cells through the CCL4-STAT3 pathway: implication for the mechanism underlying HX109 suppression of prostate hyperplasia
por: Lim, Seonung, et al.
Publicado: (2020)

Controversies in Establishing Biosimilarity: Extrapolation of Indications and Global Labeling Practices
por: Ebbers, Hans C., et al.
Publicado: (2016)

Metabolites of the Anaerobic Degradation of n‐Hexane by Denitrifying Betaproteobacterium Strain HxN1
por: Küppers, Julian, et al.
Publicado: (2019)

The Piezo1 hypothesis of renal anemia
por: Kotanko, Peter, et al.
Publicado: (2022)

CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence
por: Richards, David M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6og5vkmmrqb6c3hn34oufm3m8